# HUMIRA® Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis

> **NCT02916017** · — · COMPLETED · sponsor: **AbbVie** · enrollment: 259 (actual)

## Conditions studied

- Uveitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02916017
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-15
- **Primary completion:** 2020-10-14
- **Final completion:** 2020-10-14
- **Target enrollment:** 259 (ACTUAL)
- **Last updated:** 2021-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02916017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02916017, "HUMIRA® Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02916017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*